Applied Nanotechnologies in Anticoagulant Therapy: From Anticoagulants to Coagulation Test Performance of Drug Delivery Systems

Heparin-based delivery systems have been explored to improve their therapeutic efficacy and to reduce toxicity for different administration routes. Regardless of the applied drug delivery system (DDS), the evaluation of anticoagulant performance is instrumental for the development of a suitable DDS....

Full description

Bibliographic Details
Main Authors: Yuri B. G. Patriota, Luíse L. Chaves, Evren H. Gocke, Patricia Severino, Mônica F. R. Soares, José L. Soares-Sobrinho, Eliana B. Souto
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Applied Nano
Subjects:
Online Access:https://www.mdpi.com/2673-3501/2/2/9
_version_ 1797528090486767616
author Yuri B. G. Patriota
Luíse L. Chaves
Evren H. Gocke
Patricia Severino
Mônica F. R. Soares
José L. Soares-Sobrinho
Eliana B. Souto
author_facet Yuri B. G. Patriota
Luíse L. Chaves
Evren H. Gocke
Patricia Severino
Mônica F. R. Soares
José L. Soares-Sobrinho
Eliana B. Souto
author_sort Yuri B. G. Patriota
collection DOAJ
description Heparin-based delivery systems have been explored to improve their therapeutic efficacy and to reduce toxicity for different administration routes. Regardless of the applied drug delivery system (DDS), the evaluation of anticoagulant performance is instrumental for the development of a suitable DDS. The understanding of the range of anticoagulant assays, together with their key applications and limitations, is essential both within the context of scientific research and for clinical usage. This review provides an overview of the current anticoagulant therapy and discusses the advantages and limitations of currently available anticoagulant assays. We also discuss studies involving low-molecular-weight heparin (LMWH)-based nanocarriers with emphasis on their anticoagulation performance. Conventional anticoagulants have been used for decades for the treatment of many diseases. Direct oral anticoagulants have overcome some limitations of heparins and vitamin K antagonists. However, the lack of an accurate laboratory assessment, as well as the lack of a factor “xaban” (Xa) inhibitor reversal agent, remains a major problem associated with these anticoagulants. LMWHs represent anticoagulant agents with noteworthy efficacy and safety, and they have been explored to improve their outcomes with various nanocarriers through several administration routes. The main problems related to LMWHs have been surmounted, and improved efficiency may be achieved through the use of DDSs.
first_indexed 2024-03-10T09:53:10Z
format Article
id doaj.art-bf6da64a09a745b281dfb65a0dd87cf7
institution Directory Open Access Journal
issn 2673-3501
language English
last_indexed 2024-03-10T09:53:10Z
publishDate 2021-05-01
publisher MDPI AG
record_format Article
series Applied Nano
spelling doaj.art-bf6da64a09a745b281dfb65a0dd87cf72023-11-22T02:34:04ZengMDPI AGApplied Nano2673-35012021-05-01229811710.3390/applnano2020009Applied Nanotechnologies in Anticoagulant Therapy: From Anticoagulants to Coagulation Test Performance of Drug Delivery SystemsYuri B. G. Patriota0Luíse L. Chaves1Evren H. Gocke2Patricia Severino3Mônica F. R. Soares4José L. Soares-Sobrinho5Eliana B. Souto6Quality Control Core of Medicines and Correlates, Department of Pharmaceutical Sciences, Federal University of Pernambuco, Recife 50740-521, PE, BrazilQuality Control Core of Medicines and Correlates, Department of Pharmaceutical Sciences, Federal University of Pernambuco, Recife 50740-521, PE, BrazilDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Ege University, Bornova-Izmir 35100, TurkeyLaboratory of Nanotechnology and Nanomedicine (LNMed), Institute of Technology and Research (ITP), Av. Murilo Dantas, 300, Aracaju 49010-390, SE, BrazilQuality Control Core of Medicines and Correlates, Department of Pharmaceutical Sciences, Federal University of Pernambuco, Recife 50740-521, PE, BrazilQuality Control Core of Medicines and Correlates, Department of Pharmaceutical Sciences, Federal University of Pernambuco, Recife 50740-521, PE, BrazilFaculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, PortugalHeparin-based delivery systems have been explored to improve their therapeutic efficacy and to reduce toxicity for different administration routes. Regardless of the applied drug delivery system (DDS), the evaluation of anticoagulant performance is instrumental for the development of a suitable DDS. The understanding of the range of anticoagulant assays, together with their key applications and limitations, is essential both within the context of scientific research and for clinical usage. This review provides an overview of the current anticoagulant therapy and discusses the advantages and limitations of currently available anticoagulant assays. We also discuss studies involving low-molecular-weight heparin (LMWH)-based nanocarriers with emphasis on their anticoagulation performance. Conventional anticoagulants have been used for decades for the treatment of many diseases. Direct oral anticoagulants have overcome some limitations of heparins and vitamin K antagonists. However, the lack of an accurate laboratory assessment, as well as the lack of a factor “xaban” (Xa) inhibitor reversal agent, remains a major problem associated with these anticoagulants. LMWHs represent anticoagulant agents with noteworthy efficacy and safety, and they have been explored to improve their outcomes with various nanocarriers through several administration routes. The main problems related to LMWHs have been surmounted, and improved efficiency may be achieved through the use of DDSs.https://www.mdpi.com/2673-3501/2/2/9heparinanticoagulant drugsdrug delivery systemsanticoagulant assays
spellingShingle Yuri B. G. Patriota
Luíse L. Chaves
Evren H. Gocke
Patricia Severino
Mônica F. R. Soares
José L. Soares-Sobrinho
Eliana B. Souto
Applied Nanotechnologies in Anticoagulant Therapy: From Anticoagulants to Coagulation Test Performance of Drug Delivery Systems
Applied Nano
heparin
anticoagulant drugs
drug delivery systems
anticoagulant assays
title Applied Nanotechnologies in Anticoagulant Therapy: From Anticoagulants to Coagulation Test Performance of Drug Delivery Systems
title_full Applied Nanotechnologies in Anticoagulant Therapy: From Anticoagulants to Coagulation Test Performance of Drug Delivery Systems
title_fullStr Applied Nanotechnologies in Anticoagulant Therapy: From Anticoagulants to Coagulation Test Performance of Drug Delivery Systems
title_full_unstemmed Applied Nanotechnologies in Anticoagulant Therapy: From Anticoagulants to Coagulation Test Performance of Drug Delivery Systems
title_short Applied Nanotechnologies in Anticoagulant Therapy: From Anticoagulants to Coagulation Test Performance of Drug Delivery Systems
title_sort applied nanotechnologies in anticoagulant therapy from anticoagulants to coagulation test performance of drug delivery systems
topic heparin
anticoagulant drugs
drug delivery systems
anticoagulant assays
url https://www.mdpi.com/2673-3501/2/2/9
work_keys_str_mv AT yuribgpatriota appliednanotechnologiesinanticoagulanttherapyfromanticoagulantstocoagulationtestperformanceofdrugdeliverysystems
AT luiselchaves appliednanotechnologiesinanticoagulanttherapyfromanticoagulantstocoagulationtestperformanceofdrugdeliverysystems
AT evrenhgocke appliednanotechnologiesinanticoagulanttherapyfromanticoagulantstocoagulationtestperformanceofdrugdeliverysystems
AT patriciaseverino appliednanotechnologiesinanticoagulanttherapyfromanticoagulantstocoagulationtestperformanceofdrugdeliverysystems
AT monicafrsoares appliednanotechnologiesinanticoagulanttherapyfromanticoagulantstocoagulationtestperformanceofdrugdeliverysystems
AT joselsoaressobrinho appliednanotechnologiesinanticoagulanttherapyfromanticoagulantstocoagulationtestperformanceofdrugdeliverysystems
AT elianabsouto appliednanotechnologiesinanticoagulanttherapyfromanticoagulantstocoagulationtestperformanceofdrugdeliverysystems